Public Comments

Publish Date
Public Comments
C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities
Public Comments
C4IP Comments RE: Joint USPTO-FDA Collaboration Initiatives (PTO-P-2022-0037)
Public Comments
C4IP Comments RE: Certain Light-Based Physiological Measurement Devices and Components Thereof (337-TA-1276)
Public Comments
C4IP Comments RE: Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights (PTO-P-2022-0025)
Resources:

Resources:

C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Resources:

Resources:

C4IP Comments RE: Joint USPTO-FDA Collaboration Initiatives (PTO-P-2022-0037),

03/10/2023

Resources:

Resources:

C4IP Comments RE: Certain Light-Based Physiological Measurement Devices and Components Thereof (337-TA-1276),

02/23/2023

Resources:

Resources:

C4IP Comments RE: Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights (PTO-P-2022-0025),

01/31/2023

Scroll to Top